Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Medulloblastoma 2Glioma 2Diffuse Intrinsic Pontine Glioma 2Brain Neoplasms 2Xanthomatosis, Cerebrotendinous 1Oligodendroglioma 1Melanoma 1Influenza, Human 1Advanced Fallopian Tube Carcinoma 1

Interventions

Cyclophosphamide 15Temozolomide 11Vincristine 10Magnetic Resonance Spectroscopy 10Cisplatin 10Specimen Handling 8Radiotherapy 8Etoposide 8X-Rays 6Phantoms, Imaging 6Carboplatin 6Nuclear Medicine Department, Hospital 5Lomustine 5Radiation 4Platinum 4Methotrexate 4Irinotecan 4Filgrastim 4Biopsy 41,2-diaminocyclohexaneplatinum II citrate 4etoposide phosphate 3Thiotepa 3Nivolumab 3Granulocyte Colony-Stimulating Factor 3Celecoxib 3Bevacizumab 3Automobiles 3ulixertinib 2tipifarnib 2tazemetostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Medulloblastoma × Diphtheria-Tetanus Vaccine × 1 year × Clear all
NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT06514898 2026-04-03

MATCHPOINT

University of Florida

Phase 1 Active not recruiting
12 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡